Latest Breaking News On - Neil cashman - Page 5 : comparemela.com

Argus Research Initiates Equity Report Coverage on ProMIS Neurosciences, Inc (TSX:PMN & OTCQB: ARFXF)

/PRNewswire/ Argus Research, an independent investment research firm, has launched Argus Equity Report coverage on ProMIS Neurosciences, Inc. (TSX:PMN).

United kingdomUnited statesRudolph tanziNicholas rigopulosEpitopes dsesNeil cashmanArgus equity researchThomson reutersArgus research servicesPromis neurosciences incArgus research corpArgus research coArgus researchPrnewswire argus researchArgus equity reportFull argus equity

Complaint filed over N B top doctor s handling of mystery brain disease investigation

Complaint filed over N B top doctor s handling of mystery brain disease investigation
cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.

United kingdomNew brunswickAlier marreroEd schollenbergRoger ellisA nova scotiaSteve ellisNeil cashmanDorothy shephardBruce macfarlaneJennifer russellPublic healthCollege of physiciansHealth canadaHealth canada creutzfeldt jakob disease surveillance systemNova scotia

ProMIS Neurosciences Appoints Internationally Recognized Neuroscientist Dr Cheryl Wellington to its Scientific Advisory Board

27.01.2022 - TORONTO, Ontario and CAMBRIDGE, Mass., Jan. 27, 2022 (GLOBE NEWSWIRE) - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins .

New zealand generalNew zealandUnited kingdomUnited statesNicholas rigopulosNeil cashmanToronto stock exchangePromis neurosciences incChief scientificNorth americaScientific advisory boardCollective coordinatesDisease specific epitopesInvestor relations

Covid-19 vaccines are not associated with developing neurodegenerative diseases

The MHRA has told Full Fact there is ‘no credible evidence’ for this.

United statesUnited kingdomStephanie seneffDaniel schludiNeil cashmanRegulatory agencyArtificial intelligence laboratory in americaResearch scientistUniversity of british columbiaFull factCould causeCrippling neurodegenerative diseaseYoung peopleArtificial intelligence laboratoryFox newsCreutzfeldt jakob disease

No longer a sure thing: Records show how N B investigation into mystery illness changed over time

For three months last year, medical and environmental experts met to try to solve the mystery of a “neurological syndrome of unknown cause” in New Brunswick. But provincial public health officials halted the meetings in May.

United statesUnited kingdomNew brunswickAlier marreroDorothy shephardJoan mcgowanJennifer russellKathleen marrinerNeil cashmanDepartment of natural resourcesBrunswick department of healthDepartment of environmentHorizon health networkBrunswick public healthPublic healthPublic health new brunswick